0000000000656892

AUTHOR

Francesca Antonia Arcadi

showing 3 related works from this author

Analgesic hypnotic treatment in a post-stroke patient

2021

In recent years, hypnotic suggestions have been used in several clinical conditions. This treatment is often used for anxiety treatment, somatization, and post-traumatic stress disorder. Hypnotic analgesia is one of the most clinically useful phenomena of hypnosis. The article describes the case of a patient who underwent hypnotic treatments for hypersensitivity and chronic pain. Results showed an improvement of pain control and a decrease of pain hypersensibility. In addition, during rehabilitative treatments, the patient reported a high level of compliance with the multidisciplinary team. These findings suggest that hypnosis could be a useful treatment for post-stroke pain management.

Hypnosismedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAnalgesic050109 social psychologyHypnotic03 medical and health sciences0302 clinical medicinemedicineHumansHypnotics and Sedatives0501 psychology and cognitive sciencesPain MeasurementAnalgesicsRehabilitationbusiness.industry05 social sciencesChronic painGeneral Medicinemedicine.diseaseComplementary and alternative medicinePost strokePhysical therapyAnxietyAnalgesiamedicine.symptombusinessSomatizationHypnosis030217 neurology & neurosurgeryAmerican Journal of Clinical Hypnosis
researchProduct

Cortical Reorganization after Rehabilitation in a Patient with Conduction Aphasia Using High-Density EEG

2020

Conduction aphasia is a language disorder occurred after a left-brain injury. It is characterized by fluent speech production, reading, writing and normal comprehension, while speech repetition is impaired. The aim of this study is to investigate the cortical responses, induced by language activities, in a sub-acute stroke patient affected by conduction aphasia before and after an intensive speech therapy training. The patient was examined by using High-Density Electroencephalogram (HD-EEG) examination, while was performing language tasks. the patient was evaluated at baseline and after two months after rehabilitative treatment. Our results showed that an intensive rehabilitative process, i…

0301 basic medicineSpeech productionmedicine.medical_specialtymedicine.medical_treatmentlcsh:Technologyrehabilitationlcsh:Chemistry03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationConduction aphasiaNeuroplasticitymedicineGeneral Materials ScienceLanguage disorderInstrumentationStrokelcsh:QH301-705.5Fluid Flow and Transfer ProcessesHigh-Density EEGRehabilitationbusiness.industrylcsh:TProcess Chemistry and TechnologyGeneral Engineeringmedicine.diseaselcsh:QC1-999Computer Science ApplicationsComprehension030104 developmental biologylcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040Speech repetitionbusinessconduction aphasialcsh:Engineering (General). Civil engineering (General)brain plasticity030217 neurology & neurosurgerylcsh:PhysicsApplied Sciences
researchProduct

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhag…

2007

Increased levels of glutamate and aspartate have been detected after subarachnoid hemorrhage (SAH) that correlate with neurological status. The NMDA receptor antagonist felbamate (FBM; 2-phenyl-1,3-propanediol dicarbamate) is an anti-epileptic drug that elicits neuroprotective effects in different experimental models of hypoxia-ischemia. The aim of this dose-response study was to evaluate the effect of FBM after experimental SAH in rats on (1) behavioral deficits (employing a battery of assessment tasks days 1-5 post-injury) and (2) blood-brain barrier (BBB) permeability changes (quantifying microvascular alterations according to the extravasation of protein-bound Evans Blue by a spectropho…

Malemedicine.medical_specialtyExcitotoxicityPhenylcarbamatesBehavioral deficitsmedicine.disease_causeCisterna magnaBlood–brain barrierNeuroprotectionReceptors N-Methyl-D-AspartateFelbamateRats Sprague-Dawleychemistry.chemical_compoundInternal medicinemedicineAnimalsAnimals; Blood-Brain Barrier; Rats; Subarachnoid Hemorrhage; Evans Blue; Behavioral deficits; Cognitive deficits; NMDA receptor; FelbamatePostural BalanceEvans BlueBehavior AnimalDose-Response Relationship Drugbusiness.industryCognitive deficitsMicrocirculationBody WeightGlutamate receptorSubarachnoid HemorrhageNMDA receptorFelbamateRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsSpectrometry FluorescencechemistryBlood-Brain BarrierPropylene GlycolsAnesthesiaCerebrovascular CirculationNMDA receptorNeurology (clinical)businessmedicine.drugEvans BlueJournal of neurotrauma
researchProduct